510(k) · Cleared
ClearedOsteograf/LD-300
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dentsply International, Inc. · LYC Bone Grafting Material, Synthetic
Cleared on Aug 6, 2007 as substantially equivalent to K960353 (Ceramed Corp., 1996) and 1 other predicate after an 11-day review. Its family tree reaches back 1 generation to 1994.
- Decided
- Aug 6, 2007
- Review
- 11 days
- Class
- Class II
- Product code
- LYC
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K942212 (1994). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK942212 Osteograf/LD-300 HydroxylapatiteCeramed Corp. · 1994
- This deviceK072057 Osteograf/LD-300Dentsply International, Inc. · 2007
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K942212 | Osteograf/LD-300 Hydroxylapatite | Ceramed Corp. | 1994 | — |
| 0 (this device) | K072057 | Osteograf/LD-300 | Dentsply International, Inc. | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LYC device
- #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K960353 | Osteograf/LD-300 HydroxylapatiteSummary page 1…OsteoGraf/LD-300 CLASSIFICATION NAME: Bone Grafting Material 21 CFR 872.3930 PREDICATE DEVICES: OsteoGraf/LD-300, (K960353, K942212) DEVICE DESCRIPTION: The OsteoGraf/LD-300 material is a high purity, high density, non- resorbable, radiopaque, polycr… | 1996 |
| * | K942212 | Osteograf/LD-300 HydroxylapatiteSummary page 1…OsteoGraf/LD-300 CLASSIFICATION NAME: Bone Grafting Material 21 CFR 872.3930 PREDICATE DEVICES: OsteoGraf/LD-300, (K960353, K942212) DEVICE DESCRIPTION: The OsteoGraf/LD-300 material is a high purity, high density, non- resorbable, radiopaque, polycrystalline… | 1994 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
How does its category compare?
All LYC devicesLYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · LYC
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LYC
267in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LYC
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LYC
2in 2025
MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 13 | 80 | 0 | 23 |
| 2008 | 8 | 73 | 0 | 25 |
| 2009 | 14 | 100 | 1 | 25 |
| 2010 | 13 | 164 | 2 | 28 |
| 2011 | 9 | 224 | 0 | 21 |
| 2012 | 5 | 120 | 2 | 10 |
| 2013 | 2 | — | 0 | 12 |
| 2014 | 1 | — | 0 | 9 |
| 2015 | 0 | — | 0 | 14 |
| 2016 | 2 | — | 2 | 140 |
| 2017 | 0 | — | 0 | 19 |
| 2018 | 0 | — | 1 | 14 |
| 2019 | 0 | — | 0 | 15 |
| 2020 | 3 | 156 | 0 | 5 |
| 2021 | 0 | — | 0 | 12 |
| 2022 | 2 | — | 0 | 6 |
| 2023 | 0 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 6 |
| 2025 | 3 | 267 | 0 | 2 |
| 2026 | 3 | 266 | 0 | — |
What is it indicated for?
OsteoGraf/LD-300 is indicated for treatment of intrabony periodontal defects, augmentation of bony defects in the alveolar ridge, and filling of extraction sites.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K072057 · printed Nov 5, 2026
Cite this page
510(k) Report. “K072057: Osteograf/LD-300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072057
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026